Monash IVF Group Limited provided earnings guidance for the six months ending December 31, 2020. For the period, the company expects net profit after tax to be approximately $14 million to $14.5 million. The company's net profit after tax before certain nonregular items is expected to be approximately $11 million to $11.5 million. Earnings growth in the second half is expected to moderate as compared to the first half following recovery of pent-up demand in the first quarter. However, the company expects that earnings growth can be achieved in the second half as compared to the second half of last year, given growth in the current IVF patient pipeline and notwithstanding any further implications from COVID-19.